ADIPOSE DERIVED STROMAL CELLS FOR REFRACTORY ANGINA: RESULTS FROM MYSTROMALCELL TRIAL

Methods: MyStromalCell trial is a randomised double-blind placebo-controlled study including sixty patients with CIHD, Canadian Cardiovascular Society (CCS)/New York Heart Association (NYHA) class II-III, left ventricular ejection fraction>40% and at least one significant coronary artery stenosis...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2017-03, Vol.69 (11), p.16-16
Main Authors: Qayyum, Abbas Ali, Mathiasen, Anders, Mygind, Naja, Kuhl, Tobias, Joergensen, Erik, Helqvist, Steffen, Elberg, Jens Jørgen, Kofoed, Klaus, Vejlstrup, Niels, Fischer-Nielsen, Anne, Haack-Sørensen, Mandana, Ekblond, Annette, Kastrup, Jens
Format: Article
Language:English
Subjects:
Angina pectoris
Cardiology
Cardiovascular
Internal Medicine
Vascular endothelial growth factor
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Methods: MyStromalCell trial is a randomised double-blind placebo-controlled study including sixty patients with CIHD, Canadian Cardiovascular Society (CCS)/New York Heart Association (NYHA) class II-III, left ventricular ejection fraction>40% and at least one significant coronary artery stenosis.
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(17)33405-8